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Abstract 
 
Electrostatics of aerosols for inhalation is a relatively new research area. Charge 
properties of these particles are largely unknown but electrostatic forces have been 
proposed to potentially influence lung deposition. Investigation on the relationship 
between formulation and aerosol charging is required to understand the fundamental 
mechanisms. 
 
A modified electrical low pressure impactor was employed to measure the particles 
generated from metered dose inhalers and dry powder inhalers. This equipment 
provides detailed size and charge information of the aerosols. The particles were sized 
by impaction onto thirteen stages. The net charges in twelve of the size fractions were 
detected and recorded by sensitive electrometers. The drug deposits were quantified 
by chemical assay. 
 
The aerosol charge profiles of commercial metered dose inhalers were product-
dependent, which was due to differences in the drug, formulation, and valve stem 
material. The calculated number of elementary charges per drug particle of size ≤ 6.06 
µm ranged from zero to several ten thousands. The high charge levels on particles 
may have a potential effect on the deposition of the aerosol particles in the lung when 
inhaled. 
 
New plastic spacers marketed for use with metered dose inhalers were found to 
possess high surface charges on the internal walls, which was successfully removed 
 iii
by detergent-coating. Detergent-coated spacer had higher drug output than the new 
ones due to the reduced electrostatic particle deposition inside the spacer. Particles 
delivered from spacers carried lower inherent charges than those directly from 
metered dose inhalers. Those with higher charges might be susceptible to electrostatic 
forces inside the spacers and were thus retained. 
 
The electrostatic low pressure impactor was further modified to disperse two 
commercial Tubuhaler® products at 60 L/min. The DPIs showed drug-specific 
responses to particle charging at different RHs. The difference in hygroscopicity of 
the drugs may play a major role. A dual mechanistic charging model was proposed to 
explain the charging behaviours. The charge levels on drug particles delivered from 
these inhalers were sufficiently high to potentially affect deposition in the airways 
when inhaled. 
 
Drug-free metered dose inhalers containing HFA-134a and 227 produced highly 
variable charge profiles but on average the puffs were negatively charged, which was 
thought to be due to the electronegative fluorine atoms in the HFA molecules. The 
charges of both HFAs shifted towards neutrality or positive polarity with increasing 
water content. The spiked water might have increased the electrical conductivity 
and/or decreased the electronegativity of the bulk propellant solution. The number of 
elementary charges per droplet decreased with decreasing droplet size. This trend was 
probably due to the redistribution of charges amongst small droplets following 
electrostatic fission of a bigger droplet when the Raleigh limit was reached. 
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